5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.36▲ | 5.17▲ | 5.09▲ | 5.81▼ | 2.92▲ |
MA10 | 5.25▲ | 5.02▲ | 4.92▲ | 4.53▲ | 2.34▲ |
MA20 | 5.17▲ | 4.93▲ | 5.24▲ | 3.09▲ | 1.98▲ |
MA50 | 4.99▲ | 5.75▼ | 5.11▲ | 2.35▲ | 4.65▲ |
MA100 | 4.87▲ | 4.98▲ | 3.55▲ | 2.01▲ | 22.09▼ |
MA200 | 5.28▲ | 3.43▲ | 2.73▲ | 3.89▲ | 151.69▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.025▲ | 0.108▲ | -0.022▼ | 0.326▲ | 0.734▲ |
RSI | 75.253▲ | 57.605▲ | 54.321▲ | 67.447▲ | 62.677▲ |
STOCH | 90.836▲ | 90.346▲ | 66.776 | 70.699 | 60.299 |
WILL %R | 0.000▲ | 0.000▲ | -35.904 | -38.348 | -37.627 |
CCI | 153.113▲ | 151.720▲ | 87.045 | 59.583 | 345.676▲ |
Wednesday, August 13, 2025 09:33 AM
A simple 3-step system helped identify breakout trades like DAVE (87%), MP (45%), and OUST (56%), before they moved. Join us Wednesday to see exactly how it works, and get first access to our new ...
|
Wednesday, August 13, 2025 04:11 AM
BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that Vimal Mehta, Ph.D., ...
|
Tuesday, August 12, 2025 10:02 AM
Shares of BioXcel Therapeutics are trading sharply lower Tuesday morning. The company announced its financial results for Q2.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 4.65 | 5.49 | 4.10 | 5.48 | 9,265,684 |
14/08/25 | 5.01 | 6.23 | 4.61 | 4.75 | 8,326,221 |
13/08/25 | 7.29 | 7.36 | 5.16 | 5.60 | 15,524,091 |
12/08/25 | 5.62 | 8.08 | 4.80 | 6.80 | 35,583,620 |
11/08/25 | 4.325 | 6.69 | 4.27 | 6.40 | 42,202,873 |
08/08/25 | 3.58 | 4.68 | 3.5708 | 4.04 | 43,290,034 |
07/08/25 | 3.18 | 3.70 | 3.06 | 3.41 | 14,770,802 |
06/08/25 | 3.16 | 3.84 | 2.98 | 3.32 | 49,004,765 |
05/08/25 | 2.32 | 3.48 | 2.26 | 2.97 | 40,178,335 |
04/08/25 | 1.72 | 2.75 | 1.575 | 2.54 | 82,682,940 |
|
|
||||
|
|
||||
|
|